Erlotinib vs Simvastatin

Erlotinib vs Simvastatin: Overview

This comparison examines the pharmacological differences between Erlotinib and Simvastatin.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Simvastatin: Prodrug converted to active form that inhibits HMG-CoA reductase.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Simvastatin — 2 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Simvastatin — C25H38O5.

Molecular Weight: Erlotinib — 393.4380 g/mol; Simvastatin — 418.5700 g/mol.

Type: Erlotinib — Small molecule; Simvastatin — Small molecule.